AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal

Source: Reuters Sept 29 (Reuters) – AstraZeneca (AZN.L) will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker said on Wednesday,...